2020 Financial Year Results

2020 Financial Year Results

 

During a year of unprecedented uncertainty due to the COVID-19 pandemic, the IASO Group continued implementing its growth plan, while improving its financials and results.

At the same time, with heightened alertness and a deep sense of responsibility, the IASO Group remained at the frontline of healthcare developments, fully meeting the medical and hospitalization needs of patients, in line with the guidelines of the Greek Ministry of Health and the instructions of the Infection Control Committee.

The 2020 results for IASO, on a company and a consolidated level, as arising from the published financial statements, are listed below:

A) COMPANY

TURNOVEREarnings before interest, taxes, depreciation and amortization (EBITDA) amounted to €17.46m, as opposed to €17.02m in 2019, up by 2.6%. The corresponding margin amounted to 23.1% against sales.  

EARNINGS BEFORE TAX: The company recorded earnings before tax of €9.69m, as opposed to €4.54m in 2019, increasing by 113.4%.

EARNINGS AFTER TAX: Earnings after tax stood at €5.39m as opposed to net earnings of €3.84m in 2019, increasing by 40.4%.  

B) GROUP

TURNOVER: On a consolidated level, turnover amounted to €97.01m in 2020, as opposed to €95.71m during the previous financial year, recording a 1.4% rise.

EARNINGS BEFORE TAX: The Group ended the 2020 financial year with €3.66m in earnings before tax, as opposed to €8.89m in losses in 2019. The profitability in the 2020 financial year was affected by final consolidation accounting entries linked to the sale and deconsolidation of FILOKTITIS.

EARNINGS AFTER TAX: : In terms of results after tax, losses of €0.9m were recorded, as opposed to losses of €10.82m in 2019.

 

 

 

The strong financial position of IASO, coupled with it improving results, ensure the smooth continuation of activities. However, a potential continuation of the lockdown could have a negative effect on the purchasing power of consumers and, by extension, on the demand for private healthcare services.

The financial statements will be posted on the websites of the Athens Exchange (www.helex.gr) and the company(www.iaso.gr/en)

 

From the Press Office

For more news-related information: Thanasis Papadis, Head of the IASO Group Press Office, Tel. +30 2106383972, +30 6974441150, +30 6944346076, Ε-mail: papadis@iaso.grand Nancy Christopoulou, Commercial Division of the IASO Group, Tel.: +30 2106383917, E-mail: [email protected]

    View also:

    IASO General Clinic:One-Day Conference on “Infections in Obstetrics and Gynecology”
    GENERAL

    IASO General Clinic:One-Day Conference on “Infections in Obstetrics and Gynecology”

    IASO General Clinic in collaboration with the Internal Medicine - Infectious Diseases Clinic is organizing a One-Day Conference on the topic: “Infections in Obstetrics and Gynecology”, which will be held on Saturday, October 11th, 2025, at 09:00, at IASO Hospital’s Event Hall (37-39 Kifissias Ave, Maroussi). The aim of the Conference is to highlight the importance of early diagnosis and p...

    IASO General Clinic: Robotic mastectomy and reconstruction
    GENERAL

    IASO General Clinic: Robotic mastectomy and reconstruction

    A pioneering Robotic double Mastectomy and Reconstruction was successfully performed at IASO General Clinic on a 42-year-old woman who is a carrier of the BRCA1 gene, which is responsible for hereditary breast cancer, with the use of...

    IASO General Clinic: Advanced Medical Imaging with the New Discovery MI Gen2 PET/CT System
    GENERAL

    IASO General Clinic: Advanced Medical Imaging with the New Discovery MI Gen2 PET/CT System

    Cutting-edge technology in the service of personalized care IASO Group is ushering in a new era in diagnostic imaging through the installation...